tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shandong Xinhua Pharmaceutical Proposes Amendments to Articles of Association

Story Highlights
Shandong Xinhua Pharmaceutical Proposes Amendments to Articles of Association

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.

Shandong Xinhua Pharmaceutical Company Limited has announced proposed amendments to its Articles of Association to comply with new regulatory requirements in China. These changes include abolishing the Supervisory Committee, transferring its functions to the Audit Committee, adjusting powers of the Shareholders’ meeting and the Board, and revising the business scope description. The amendments are subject to shareholder approval at a general meeting.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.

Average Trading Volume: 8,369,606

Technical Sentiment Signal: Buy

Current Market Cap: HK$10.52B

For a thorough assessment of 0719 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1